SEC Form 4 · accession 0001209191-15-072793
Zosano Pharma Corp · ZSAN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Konstantinos Alataris
Officer — President
Period of report
Sep 21, 2015
Accepted (ET)
Oct 1, 2015 · 4:58 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001587221
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $8.18 | Sep 21, 2015 | A | 48,896 | A | — | Sep 21, 2025 | Common Stock | 48,896 | 48,896 | D |
| Employee Stock Option (right to buy)F1 | $8.18 | Sep 21, 2015 | A | 160,498 | A | — | Sep 21, 2025 | Common Stock | 160,498 | 209,394 | D |
Explanation of responses
- F125% of the total number of shares underlying the stock option vest on September 21, 2016, and the remaining underlying shares vest in equal monthly installments over the following three-year period.